IL-17 and IFN-γ expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease
about
Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and BiomarkersFunctional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosisBiology of IL-27 and its role in the host immunity against Mycobacterium tuberculosisMycobacterium bovis Infection of Cattle and White-Tailed Deer: Translational Research of Relevance to Human TuberculosisAllele-specific induction of IL-1β expression by C/EBPβ and PU.1 contributes to increased tuberculosis susceptibilityCD4+ T cells contain early extrapulmonary tuberculosis (TB) dissemination and rapid TB progression and sustain multieffector functions of CD8+ T and CD3- lymphocytes: mechanisms of CD4+ T cell immunity.A genomic portrait of the genetic architecture and regulatory impact of microRNA expression in response to infection.Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection.Decreased expression of perforin in CD8+ T lymphocytes in patients with Mycobacterium tuberculosis infection and its potential value as a marker for efficacy of treatment.Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense.Phosphorylated STAT3 and PD-1 regulate IL-17 production and IL-23 receptor expression in Mycobacterium tuberculosis infectionExpansion of pathogen-specific mono- and multifunctional Th1 and Th17 cells in multi-focal tuberculous lymphadenitis.Decreased expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4⁺ T cells and peripheral blood from tuberculosis patientsIncreased cytokines response in patients with tuberculosis complicated with chronic obstructive pulmonary disease.T Cell Activation and Proinflammatory Cytokine Production in Clinically Cured Tuberculosis Are Time-Dependent and Accompanied by Upregulation of IL-10.Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice.Impaired M. tuberculosis Antigen-Specific IFN-γ Response without IL-17 Enhancement in Patients with Severe Cavitary Pulmonary TuberculosisB Cells and Programmed Death-Ligand 2 Signaling Are Required for Maximal Interferon-γ Recall Response by Splenic CD4⁺ Memory T Cells of Mice Vaccinated with Mycobacterium tuberculosis Ag85B.IFNG-mediated immune responses enhance autophagy against Mycobacterium tuberculosis antigens in patients with active tuberculosis.Overexpression of RORγt Enhances Pulmonary Inflammation after Infection with Mycobacterium Avium.Cytokine Profiles from Antigen-Stimulated Whole-Blood Samples among Patients with Pulmonary or Nonmeningeal Disseminated Coccidioidomycosis.A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans.Tuberculous pleurisy drives marked effector responses of γδ, CD4+, and CD8+ T cell subpopulations in humans.Elevated Neopterin Levels Are Associated with Increased Tuberculosis Risk in Rheumatoid Arthritis Patients with QuantiFERON Conversion during Biologic Therapy.Reduced frequency of memory T cells and increased Th17 responses in patients with active tuberculosisInvestigation of microRNA expression and DNA repair gene transcripts in human oocytes and blastocysts.Phosphorylation of mitogen-activated protein kinases contributes to interferon γ production in response to Mycobacterium tuberculosis.Interleukin-17A as a Biomarker for Bovine TuberculosisMicroRNA expression and its association with DNA repair in preimplantation embryos.Evaluation of Interleukin17and Interleukin 23 expression in patients with active and latent tuberculosis infection.S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosisEvaluation of the overall IFN-γ and IL-17 pro-inflammatory responses after DNA therapy of tuberculosis.The IL-17A rs2275913 single nucleotide polymorphism is associated with protection to tuberculosis but related to higher disease severity in Argentina.Definition of CD4 Immunosignatures Associated with MTB.Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases.Receptor-mediated recognition of mycobacterial pathogens.T cells and adaptive immunity to Mycobacterium tuberculosis in humans.DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.Ratio of T-Helper Type 1 (Th1) to Th17 Cytokines in Whole Blood Is Associated With Human β-Defensin 3 Expression in Skin and Persistent Staphylococcus aureus Nasal Carriage.CD4+ and γδ T Cells are the main Producers of IL-22 and IL-17A in Lymphocytes from Mycobacterium bovis-infected Cattle.
P2860
Q26774207-26466DAC-CE7E-4EA7-A7CA-38AD80648946Q26849399-66147713-ADF6-49F7-B116-27A020C91C4DQ27014743-A279815C-1338-4F76-AB3E-6EB66B046A01Q28083909-C03F707D-30B8-4A6F-8DAE-7E4FE19E906DQ28396007-8B3D1A4A-D040-4626-A2F2-D0FF177489B4Q30584398-5E9985A8-4C0A-4013-80A4-9490D2A1E551Q33564551-627E391D-F072-40A5-A48E-685B8DCD7A82Q33619034-9F54186D-F6E4-4CCC-AEBE-88540C453A4FQ33780245-8B294716-044E-46F3-90B1-3E6119655ACDQ33788735-9C361C04-7E8C-4B2B-BD60-DDA7190D3352Q33934027-4571A92A-7C6F-4441-9FEC-EFAEE4867023Q34603041-9F0E8490-E518-4405-B4F1-3DFACD59A89AQ34684639-ECA81900-79D4-4296-B650-36FB3355BF90Q34693098-19088175-1422-45A7-AD66-219F6172BF63Q34793513-29FB8A62-6588-48E9-BE41-0EE509B2B075Q35032532-3D56AB1C-14D3-4582-AEB9-870659935C03Q35643864-FAE58D61-B826-45ED-8976-504A88EB55A0Q35778676-7C5550A0-08CE-49B8-9337-2A2016844D9AQ35852762-F904CDE6-998D-47AC-8609-570309974D53Q35897823-569A048A-46E4-4881-936D-EE31C38C504FQ35901986-43C8663D-F1D7-4234-86BB-07CA782B8423Q36074922-838BA00B-A7A6-490A-A474-776D85437093Q36143399-F9A30C25-6AA4-4EC8-A4E4-53A24DABAD74Q36197198-5E8955CB-0D69-4ECE-A146-82844D65E0DBQ36362277-5176F180-26E4-4969-B437-D9EBEF134F2DQ36378546-A0F4C08B-9829-4FFA-AA18-8250EEC31CBDQ36495576-06147A92-0387-4C5C-A11F-2DB9F8EBC4A0Q36555072-EDA580F1-5E68-4637-AE18-A0E778FF0178Q37034049-63B43EF2-4AF3-47B2-9C54-068AEFBCAB59Q37306934-CD031894-599D-457A-BA2B-E86BE86A9C3FQ37393658-A86B9484-46D9-4AC4-8773-C1C3CFE958FAQ37505396-5084751C-9E86-453E-B92D-B705BE3A4E96Q37591092-C939C54D-157E-45B6-84CF-DE842A9711BAQ37672921-973A3766-25C7-4CB9-B82D-1B377AD6A9D9Q37737549-355F7015-98EB-4E40-BF43-2BB3F207D467Q38116540-601A6AEA-3529-49D0-8D88-76BB9E97E60BQ38363792-B33FA839-14D9-436F-BAFB-6267BCD83B3DQ38751464-43B6DEA7-1247-47BE-83B4-550F9A0808A5Q39312275-433412C2-9526-4E93-9C08-79461EA80EE8Q39592498-BB5B29EB-76BA-4381-9F5B-4478B1D22C25
P2860
IL-17 and IFN-γ expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
IL-17 and IFN-γ expression in ...... th the severity of the disease
@ast
IL-17 and IFN-γ expression in ...... th the severity of the disease
@en
type
label
IL-17 and IFN-γ expression in ...... th the severity of the disease
@ast
IL-17 and IFN-γ expression in ...... th the severity of the disease
@en
prefLabel
IL-17 and IFN-γ expression in ...... th the severity of the disease
@ast
IL-17 and IFN-γ expression in ...... th the severity of the disease
@en
P2093
P2860
P356
P1476
IL-17 and IFN-γ expression in ...... th the severity of the disease
@en
P2093
Ana I Rovetta
Delfina Peña
Domingo Palmero
H Eduardo Chuluyán
Horacio E Romeo
Ivana B Alvarez
Javier O Jurado
Nancy L Tateosian
Rosa M Musella
Verónica E García
P2860
P304
P356
10.1189/JLB.1211619
P577
2012-03-13T00:00:00Z